US 11525002
Human PD-L1 antibodies and methods of use therefor
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 11525002 (Human PD-L1 antibodies and methods of use therefor) held by The Board of Regents of the University of Texas System expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61P, A61P35/00